{
  "query": "improvement score clinical ibdq",
  "studies": {
    "protocolSection": [
      {
        "identificationModule": {
          "nctId": "NCT00294112",
          "briefTitle": "Prochymal™ Adult Human Mesenchymal Stem Cells for Treatment of Moderate-to-severe Crohn's Disease"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2006-03-13",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2006-07-21",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Crohn's Disease"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 10,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "70 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02463305",
          "briefTitle": "Therapeutic Modulation of the Intestinal Creatine Kinase System in Inflammatory Bowel Disease (IBD)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-08",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2023-03-01",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Colitis, Ulcerative"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 0,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "70 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03566823",
          "briefTitle": "Efficacy and Safety Study of Ontamalimab as Induction Therapy in Participants With Moderate to Severe Crohn's Disease (CARMEN CD 306)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-07-17",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-08-18",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Crohn's Disease"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 34,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "16 Years",
          "maximumAge": "80 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06589986",
          "briefTitle": "A Study to Assess the Efficacy and Safety of Afimkibart (Also Known as RO7790121) for Induction and Maintenance Therapy in Participants With Moderately to Severely Active Ulcerative Colitis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-09-17",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2029-12-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Moderately to Severely Active Ulcerative Colitis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 400,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "16 Years",
          "maximumAge": "80 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03345849",
          "briefTitle": "A Study of the Efficacy and Safety of Upadacitinib in Participants With Moderately to Severely Active Crohn's Disease Who Have Inadequately Responded to or Are Intolerant to Conventional and/or Biologic Therapies"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-12-07",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-01-13",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Crohn's Disease"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 526,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00790933",
          "briefTitle": "An Open-label Study of Vedolizumab (MLN0002) in Participants With Ulcerative Colitis and Crohn's Disease"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2009-05-22",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2017-10-31",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Ulcerative Colitis", "Crohn's Disease"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 2243,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06721962",
          "briefTitle": "Treatment of Moderate to Severe Refractory Crohn's Disease"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-05-05",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-01-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Crohns Disease"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 39,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01514240",
          "briefTitle": "Phase III Study of D9421-C 9 mg in Patients With Active Crohn's Disease in Japan"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2012-02"
          },
          "completionDateStruct": {
            "date": "2014-09",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Crohn's Disease"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 123,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "15 Years",
          "maximumAge": "130 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06408935",
          "briefTitle": "Transmural Healing and Disease-Modifying Effect of Guselkumab in Crohn's Disease Patients"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-04-17",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2028-03-26",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Crohn's Disease"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 112,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02365649",
          "briefTitle": "A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of ABT-494 for the Induction of Symptomatic and Endoscopic Remission in Subjects With Moderately to Severely Active Crohn's Disease Who Have Inadequately Responded to or Are Intolerant to Immunomodulators or Anti-TNF Therapy"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2015-03-17",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2017-08-03",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Crohn's Disease"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 220,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00055497",
          "briefTitle": "Remission in Subjects With Crohn's Disease, 1 Year Phase"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2002-08"
          },
          "completionDateStruct": {
            "date": "2008-12",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Crohn's Disease"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 276,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03074656",
          "briefTitle": "The Norwegian Drug Monitoring Study"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-03-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-12-14",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Rheumatoid Arthritis", "Spondyloarthritis", "Ankylosing Spondylitis", "Crohn Disease", "Ulcerative Colitis", "Psoriasis", "Psoriatic Arthritis"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 611,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06975722",
          "briefTitle": "A Study to Investigate the Efficacy and Safety of SAR442970 in Adult Participants With Ulcerative Colitis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-07-07",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2029-10-17",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Ulcerative Colitis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 99,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06637631",
          "briefTitle": "A Study to Investigate Efficacy and Safety of SAR441566 in Patients With Crohn's Disease."
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-12-10",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2029-05-23",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Crohn's Disease"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 260,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06958536",
          "briefTitle": "A Study to Investigate Efficacy and Safety of SAR442970 in Patients With Crohn's Disease"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-06-03",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2029-10-17",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Crohn's Disease"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 99,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00445432",
          "briefTitle": "A Study of Adalimumab for the Maintenance of Clinical Remission in Japanese Subjects With Crohn's Disease"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2007-03"
          },
          "completionDateStruct": {
            "date": "2010-11",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Crohn's Disease"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 82,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "15 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00737230",
          "briefTitle": "Care of Cancer Patients With Bowel Injury Caused by Radiation Therapy to the Pelvis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2007-04"
          },
          "completionDateStruct": {
            "date": "2012-07",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Cancer"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 250,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02822235",
          "briefTitle": "Non-interventional Study of Moderate to Severe Inflammatory Bowel Disease in Brazil"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-10-11",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2018-02-19",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Inflammatory Bowel Disease"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 407,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03398135",
          "briefTitle": "A Study to Assess the Efficacy and Safety of Risankizumab in Participants With Ulcerative Colitis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-08-28",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2029-02",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Ulcerative Colitis (UC)"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 1242,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "16 Years",
          "maximumAge": "80 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT07302360",
          "briefTitle": "A Real-World Study of Guselkumab in Chinese Participants With Ulcerative Colitis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2026-01-31",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2028-06-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Colitis, Ulcerative"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 200,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05574387",
          "briefTitle": "Metformin as Added on Therapy in Patients With Ulcerative Colitis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-01-20",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-04",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Inflammatory Bowel Diseases"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 46,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06254950",
          "briefTitle": "A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Ulcerative Colitis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-03-29",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-08-04",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Ulcerative Colitis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 207,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06742385",
          "briefTitle": "Evaluation of a Remote Monitoring Application in the Follow-up of Patients With Active Inflammatory Bowel Diseases"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-09-18",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2028-09-18",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Crohn Disease", "Ulcerative Colitis"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 290,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "80 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01897090",
          "briefTitle": "A Crohn's Disease Diet to Reduce Symptoms of Crohn's Disease"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2013-01"
          },
          "completionDateStruct": {
            "date": "2014-01",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Crohn's Disease"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 0,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03105128",
          "briefTitle": "A Study of the Efficacy and Safety of Risankizumab in Participants With Moderately to Severely Active Crohn's Disease"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-05-10",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-04-14",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Crohn's Disease"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 931,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "16 Years",
          "maximumAge": "80 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02646683",
          "briefTitle": "A Study to Evaluate Efficacy, of Early Versus Late Use of Vedolizumab in Crohn's Disease: the LOVE-CD Study"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2015-07",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-05-26",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Crohn Disease"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 260,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "80 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00307931",
          "briefTitle": "Certolizumab Pegol for Treatment of Adult Greek Patients With Moderate to Severe Crohn's Disease Who Failed Infliximab"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2007-04"
          },
          "completionDateStruct": {
            "date": "2008-08",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Crohn's Disease"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 16,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03107793",
          "briefTitle": "Study of Treat to Target Versus Routine Care Maintenance Strategies in Crohn's Disease Patients Treated With Ustekinumab"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-04-19",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-07-20",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Crohn Disease"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 500,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02136069",
          "briefTitle": "A Study Comparing the Efficacy and Safety of Etrolizumab to Infliximab in Participants With Moderate to Severe Ulcerative Colitis Who Are Naïve to Tumor Necrosis Factor (TNF) Inhibitors"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2014-12-24",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-06-23",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Ulcerative Colitis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 397,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "80 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05370885",
          "briefTitle": "VE202 in Patients With Mild-to-Moderate Ulcerative Colitis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-05-08",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-08-29",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Ulcerative Colitis", "Colitis, Ulcerative"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 114,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00329420",
          "briefTitle": "Maintenance Study Including Re-induction Therapy for Patients Who Did Not Show a Clinical Effect in Study C87037 (NCT00291668)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2006-05"
          },
          "completionDateStruct": {
            "date": "2008-05",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Crohn's Disease"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 46,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "16 Years",
          "maximumAge": "64 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02165215",
          "briefTitle": "A Study of the Efficacy and Safety of Etrolizumab Treatment in Maintenance of Disease Remission in Ulcerative Colitis (UC) Participants Who Are Naive to Tumor Necrosis Factor (TNF) Inhibitors"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2014-08-12",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-04-06",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Colitis, Ulcerative"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 359,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "80 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00317356",
          "briefTitle": "A Dose-finding Study of OPC-6535 in Patients With Active Ulcerative Colitis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2006-05"
          },
          "completionDateStruct": {
            "date": "2007-08",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Colitis, Ulcerative"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 43,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06588855",
          "briefTitle": "A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (Also Known as RO7790121) in Participants With Moderately to Severely Active Ulcerative Colitis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-12-11",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2029-12-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Moderately to Severely Active Ulcerative Colitis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 350,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "16 Years",
          "maximumAge": "80 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT07185009",
          "briefTitle": "A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2026-01-07",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2033-04-28",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Ulcerative Colitis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 671,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "16 Years",
          "maximumAge": "80 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06052059",
          "briefTitle": "A Study to Evaluate Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderately to Severely Active Ulcerative Colitis (MK-7240-001)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-10-25",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2029-08-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Ulcerative Colitis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 1020,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "16 Years",
          "maximumAge": "80 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02277470",
          "briefTitle": "Study of the Pharmacokinetics of Golimumab in Moderate to Severe Ulcerative Colitis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2014-08"
          },
          "completionDateStruct": {
            "date": "2016-08",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Ulcerative Colitis"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 20,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02163759",
          "briefTitle": "A Study Comparing the Efficacy and Safety of Etrolizumab With Adalimumab and Placebo in Participants With Moderate to Severe Ulcerative Colitis (UC) in Participants Naive to Tumor Necrosis Factor (TNF) Inhibitors"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2014-11-04",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-03-19",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Ulcerative Colitis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 358,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "80 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03006198",
          "briefTitle": "Tracking Biologics Along the Silk Road"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-02-04",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2018-12-01",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Arthritis, Rheumatoid; Spondylitis, Ankylosing; Arthritis, Psoriatic; Colitis, Ulcerative"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 140,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03259334",
          "briefTitle": "Efficacy and Safety Study of SHP647 as Induction Therapy in Participants With Moderate to Severe Ulcerative Colitis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-02-09",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-10-23",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Ulcerative Colitis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 380,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "16 Years",
          "maximumAge": "80 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00349752",
          "briefTitle": "Corticosteroid Sparing Effect of Certolizumab in Crohn's Disease"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2006-11"
          },
          "completionDateStruct": {
            "date": "2009-07",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Crohn's Disease"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 174,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02171429",
          "briefTitle": "A Study Comparing the Efficacy and Safety of Etrolizumab With Adalimumab and Placebo in Participants With Moderate to Severe Ulcerative Colitis (UC) in Participants Naive to Tumor Necrosis Factor (TNF) Inhibitors"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2014-11-14",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-05-25",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Ulcerative Colitis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 358,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "80 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06754891",
          "briefTitle": "Clinical Trial of TQH3906 Capsules for the Treatment of Adult Patients With Moderately to Severely Active Ulcerative Colitis or Crohn's Disease"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-01",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2027-12",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Inflammatory Bowel Diseases"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 116,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01149707",
          "briefTitle": "Safety, Tolerability, Efficacy Study of PUR 0110 Rectal Enema in Mild-to-Moderate Distal Ulcerative Colitis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2010-06-01"
          },
          "completionDateStruct": {
            "date": "2015-06-20",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Left-Sided Ulcerative Colitis", "Proctosigmoiditis"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 34,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04164849",
          "briefTitle": "Extracorporeal Photopheresis of Patients With Crohn's Disease Using 5-aminolevulinic Acid"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-11-22",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-10-31",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Crohn Disease"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 7,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05588843",
          "briefTitle": "Dose-finding Study of SAR443122 in Adult Participants With Ulcerative Colitis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-11-25",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-12-16",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Colitis Ulcerative"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 182,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04996797",
          "briefTitle": "A Phase 2 Safety and Efficacy Study of Tulisokibart (MK-7240/PRA023) in Subjects With Moderately to Severely Active Ulcerative Colitis (MK-7240-005)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-07-14",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-07-14",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Ulcerative Colitis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 178,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04154735",
          "briefTitle": "Autologous Transplant Targeted Against Crohn's"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-11",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2024-03",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Crohn's Disease"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 0,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "49 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00329550",
          "briefTitle": "Maintenance Study of Certolizumab Pegol (CZP) in Crohn's Disease"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2006-05"
          },
          "completionDateStruct": {
            "date": "2008-04",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Crohn's Disease"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 40,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "16 Years",
          "maximumAge": "64 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06896305",
          "briefTitle": "Impact of Exclusion Diet in Addition to Anti-TNF Therapy in Crohn's Disease and Ulcerative Colitis: a Prospective, Double Arm, Open-label Study"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-04-01",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2027-10-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Ulcerative Colitis (UC)", "Crohn Disease (CD)"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 60,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06109441",
          "briefTitle": "Efficacy/Safety of ALTB-268 in Subjects w/Moderately to Severely Active UC Refractory to Biologics"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-12-04",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-03",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Ulcerative Colitis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 50,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05262829",
          "briefTitle": "Clinical Study of Human Umbilical Cord Mesenchymal Stem Cells in the Treatment of Moderate and Severe Crohn's Disease"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-02-28",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-01-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Crohn Disease"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 40,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "70 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05584228",
          "briefTitle": "Medical Treatment Versus Surgery in Stricturing Small Bowel Crohn's Disease"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-04-01",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2027-10-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Crohn Disease"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 150,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "70 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01320436",
          "briefTitle": "Curcumin + Aminosalicylic Acid (5ASA) Versus 5ASA Alone in the Treatment of Mild to Moderate Ulcerative Colitis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2011-07"
          },
          "completionDateStruct": {
            "date": "2014-10",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Ulcerative Colitis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 50,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "70 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03298022",
          "briefTitle": "Efficacy&Safety of ALTB-168 in Patients With Moderate to Severe Active,Anti-TNF Alpha and/or Anti-integrin Refractory UC"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-05-04",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-06-01",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Ulcerative Colitis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 24,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00073021",
          "briefTitle": "Safety and Efficacy of Two Different Doses of Asacol in the Treatment of Moderately Active Ulcerative Colitis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2000-09"
          },
          "completionDateStruct": {
            "date": "2003-09",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Ulcerative Colitis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 386,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06725017",
          "briefTitle": "A Phase 2 Study to Evaluate the Efficacy and Safety of Live SK08 Powder in Adult Patients with Active Mild to Moderate Ulcerative Colitis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-07-01",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2027-08-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Ulcerative Colitis (UC)"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 60,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02819635",
          "briefTitle": "A Study to Evaluate the Safety and Efficacy of Upadacitinib (ABT-494) for Induction and Maintenance Therapy in Participants With Moderately to Severely Active Ulcerative Colitis (UC)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-09-26",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-12-13",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Ulcerative Colitis (UC)"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 1302,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "16 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02407236",
          "briefTitle": "A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction and Maintenance Therapy in Participants With Moderately to Severely Active Ulcerative Colitis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2015-07-10",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-11-30",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Colitis, Ulcerative", "Inflammatory Bowel Diseases"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 961,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00291668",
          "briefTitle": "Clinical Study of CDP870/Certolizumab Pegol in Patients With Active Crohn's Disease"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2006-03-02",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2007-11-08",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Crohn's Disease"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 94,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "16 Years",
          "maximumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05347095",
          "briefTitle": "A Study of Guselkumab in Participants With Fistulizing, Perianal Crohn's Disease"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-09-27",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-03-25",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Fistulizing Crohns Disease", "Perianal Crohns Disease"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 288,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01620255",
          "briefTitle": "A Study Of PF-00547659 In Patients With Moderate To Severe Ulcerative Colitis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2012-11-02",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2016-02-04",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Ulcerative Colitis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 357,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06786507",
          "briefTitle": "A Direct Head-to-head Comparison of Ustekinumab with Infliximab for the Treatment of Ulcerative Colitis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-05-15",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2026-10-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Ulcerative Colitis (UC)"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 100,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "80 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01070303",
          "briefTitle": "Remission in Subjects With Crohn's Disease, Open Label Extension"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2002-08"
          },
          "completionDateStruct": {
            "date": "2008-12",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Crohn's Disease"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 177,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01316939",
          "briefTitle": "GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2011-05-09",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2013-10-23",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Crohn's Disease"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 229,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02048618",
          "briefTitle": "Efficacy and Safety of GLPG0634 in Subjects With Active Crohn's Disease"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2014-02"
          },
          "completionDateStruct": {
            "date": "2016-02",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Crohn's Disease"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 175,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT07184996",
          "briefTitle": "An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-10-08",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2028-05-09",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Ulcerative Colitis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 980,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "16 Years",
          "maximumAge": "80 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03345836",
          "briefTitle": "A Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Participants With Moderately to Severely Active Crohn's Disease Who Have Inadequately Responded to or Are Intolerant to Biologic Therapy"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-11-29",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-08-11",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Crohn's Disease"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 624,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03104413",
          "briefTitle": "A Study to Assess the Efficacy and Safety of Risankizumab in Participants With Moderately to Severely Active Crohn's Disease Who Failed Prior Biologic Treatment"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-12-18",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-05-19",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Crohn's Disease"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 618,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "16 Years",
          "maximumAge": "80 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02100696",
          "briefTitle": "A Study of the Efficacy and Safety of Etrolizumab in Participants With Ulcerative Colitis Who Have Been Previously Exposed to Tumor Necrosis Factor (TNF) Inhibitors"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2014-05-21",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-04-16",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Ulcerative Colitis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 609,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "80 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01235689",
          "briefTitle": "Efficacy and Safety of Two Treatment Algorithms in Adults With Moderate to Severe Crohn's Disease"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2011-02-11",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2017-01-03",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Crohn's Disease"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 252,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00573794",
          "briefTitle": "Long-term Open-label Safety and Efficacy Study of Adalimumab in Subjects With Ulcerative Colitis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2007-11-28",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2016-12",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Ulcerative Colitis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 592,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02849951",
          "briefTitle": "A Study to Investigate the Safety and Efficacy of LT-02 in Patients With Mesalamine Refractory Ulcerative Colitis (UC)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-07"
          },
          "completionDateStruct": {
            "date": "2019-08",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Ulcerative Colitis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 25,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "70 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04969679",
          "briefTitle": "Additive Effect of Probiotics (Mutaflor®) in Patients With Ulcerative Colitis on 5-ASA Treatment."
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-03-16",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-06-03",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Ulcerative Colitis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 134,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "19 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03905109",
          "briefTitle": "Phase 2b/3 Study of ABX464 in Moderate to Severe Active Crohn's Disease Patients"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-09-19",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2022-09-19",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Crohn Disease"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 0,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03482635",
          "briefTitle": "BI655130 (SPESOLIMAB) Induction Treatment in Patients With Moderate-to-severe Ulcerative Colitis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-03-27",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-05-18",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Colitis, Ulcerative"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 98,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02522767",
          "briefTitle": "Mesalamine 4 g Sachet for the Induction of Remission in Active, Mild to Moderate Ulcerative Colitis (UC)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2015-10",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2018-04-03",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Ulcerative Colitis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 228,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01318993",
          "briefTitle": "Open-Label Extension Study of GSK1605786A"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2011-04-01"
          },
          "completionDateStruct": {
            "date": "2013-10-29",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Crohn's Disease"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 399,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04842149",
          "briefTitle": "The Effects of Bifidobacterium Breve Bif195 for Small Intestinal Crohn's Disease"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-05-21",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-11-30",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Crohn Disease"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 33,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05606419",
          "briefTitle": "The Crohn's Disease Exclusion Diet With Early Dairy Introduction vs Partial Enteral Nutrition for Crohn's Disease"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-03-10",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-09",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Crohn Disease"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 44,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05767021",
          "briefTitle": "A Study of Mirikizumab (LY3074828) in Participants With Moderately to Severely Active Ulcerative Colitis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-05-17",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-04",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Ulcerative Colitis", "Ulcerative Colitis Chronic"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 172,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01090817",
          "briefTitle": "An Australian Study of Mesenchymal Stromal Cells for Crohn's Disease"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2010-01"
          },
          "completionDateStruct": {
            "date": "2015-06",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Crohn Disease"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 21,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "55 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05988528",
          "briefTitle": "Clinical Study to Evaluate the Possible Efficacy of Nifuroxazide in Patient With Ulcerative Colitis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-08-20",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-02-20",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Inflammatory Bowel Diseases"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 50,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "60 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00317369",
          "briefTitle": "A Dose-finding Study of OPC-6535 in Patients With Active Crohn's Disease"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2006-05"
          },
          "completionDateStruct": {
            "date": "2007-08",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Crohn Disease"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 29,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "16 Years",
          "maximumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06867939",
          "briefTitle": "A Study of Curcumin (Soloways ™) in Patients With Inflammatory Bowel Disease Homozygous for the IL-10 Variant"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-05-05",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-02-02",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Inflamatory Bowel Disease"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 40,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "70 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05471492",
          "briefTitle": "Study to Evaluate the Efficacy and Safety of PF-06480605 in Adult Participants With Moderate to Severe Crohn's Disease"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-07-30",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2026-08-15",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Crohn Disease"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 0,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05121402",
          "briefTitle": "Safety and Efficacy Study of TLL018 in the Treatment of Ulcerative Colitis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-12-30",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2023-12-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Ulcerative Colitis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 0,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01545050",
          "briefTitle": "Dose Ranging Study of BMS-945429 in Subjects With Moderate to Severe Crohn's Disease"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2012-06"
          },
          "completionDateStruct": {
            "date": "2013-12",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Crohn's Disease"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 72,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04985968",
          "briefTitle": "The Efficacy and Safety of Cobitolimod in Participants With Moderate to Severe Active Left-Sided Ulcerative Colitis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-11-24",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-12-20",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Ulcerative Colitis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 171,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02790138",
          "briefTitle": "A Study to Evaluate the Efficacy and Safety of Vedolizumab in the Treatment of Chronic Pouchitis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-10-12",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-02-02",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Pouchitis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 102,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "80 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05369832",
          "briefTitle": "An Open-label Study of Ozanimod in Moderate to Severe Ulcerative Colitis in Clinical Practice"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-12-16",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-04-11",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Colitis, Ulcerative"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 139,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03559517",
          "briefTitle": "Efficacy and Safety Study of Ontamalimab as Induction Therapy in Participants With Moderate to Severe Crohn's Disease (CARMEN CD 305)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-08-29",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-10-08",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Crohn's Disease"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 30,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "16 Years",
          "maximumAge": "80 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02065622",
          "briefTitle": "Study to Evaluate the Safety and Efficacy of Two Adalimumab Dosing Regimens in Subjects With Moderate to Severe Ulcerative Colitis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2014-03-27",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2019-11-11",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Ulcerative Colitis (UC)"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 952,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03259308",
          "briefTitle": "Efficacy and Safety Study of SHP647 as Induction Therapy in Participants With Moderate to Severe Ulcerative Colitis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-12-05",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-10-06",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Ulcerative Colitis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 279,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "16 Years",
          "maximumAge": "80 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02760940",
          "briefTitle": "Anemia in Inflammatory Bowel Disease"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-08"
          },
          "completionDateStruct": {
            "date": "2018-08",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Anemia", "Bowel Diseases, Inflammatory"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 200,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02782663",
          "briefTitle": "A Study to Evaluate the Long-Term Efficacy, Safety, and Tolerability of Repeated Administration of Upadacitinib (ABT-494) in Participants With Crohn's Disease"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-05-18",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-07-18",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Crohn's Disease (CD)"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 107,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06764615",
          "briefTitle": "A Continuation Study of TAK-279 in Adults With Ulcerative Colitis (UC) and Crohn's Disease (CD)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-05-28",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2029-12-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Crohn's Disease", "Ulcerative Colitis"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 183,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "76 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT07196722",
          "briefTitle": "A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-10-03",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2032-10-06",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Crohn Disease"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 1092,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02513459",
          "briefTitle": "A Long Term Extension Trial of BI 655066/ABBV-066 (Risankizumab), in Patients With Moderately to Severely Active Crohn's Disease"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2015-09-16",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2019-06-19",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Crohn Disease"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 65,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06095128",
          "briefTitle": "A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-06-12",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-07-09",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Ulcerative Colitis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 65,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "65 Years"
        }
      }
    ],
    "protocolSection.1": [
      {
        "identificationModule": {
          "nctId": "NCT02958865",
          "briefTitle": "Study to Compare Oral PF-06651600, PF-06700841 and Placebo in Subjects With Moderate to Severe Ulcerative Colitis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-02-03",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-05-10",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Ulcerative Colitis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 319,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01470599",
          "briefTitle": "A Open-Label Study Of CP-690,550 As Long-Term Therapy (48 Weeks) In Subjects With Crohn's Disease"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2012-04",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2016-07",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Crohn's Disease"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 150,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "76 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01393626",
          "briefTitle": "A Study To Investigate Safety And Efficacy Of CP-690,550 For Induction Therapy In Subjects With Moderate To Severe Crohn's Disease"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2011-10"
          },
          "completionDateStruct": {
            "date": "2015-03",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Crohn's Disease"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 280,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00194818",
          "briefTitle": "Asacol Dosing Study for Active Ulcerative Colitis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2003-06"
          },
          "completionDateStruct": {
            "date": "2007-08",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Ulcerative Colitis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 7,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "80 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06598943",
          "briefTitle": "A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-10-10",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2028-09",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Ulcerative Colitis", "Ulcerative Colitis Chronic"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 140,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03653026",
          "briefTitle": "A Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Participants With Moderately to Severely Active Ulcerative Colitis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-12-06",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-01-14",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Ulcerative Colitis (UC)"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 522,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "16 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02589665",
          "briefTitle": "A Study of Mirikizumab (LY3074828) in Participants With Moderate to Severe Ulcerative Colitis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2015-12-09",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2019-05-07",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Ulcerative Colitis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 249,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05330299",
          "briefTitle": "Acceptability of Identifying and Managing Psychological Distress in Inflammatory Bowel Disease: the COMPASS-IBD Study"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-12-02",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-02-29",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["IBD", "Psychological Distress", "Treatment of Illness-related Distress in IBD"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 108,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00787202",
          "briefTitle": "A Study To Investigate The Safety And Efficacy Of CP- 690,550 In Patients With Moderate And Severe Ulcerative Colitis."
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2008-12"
          },
          "completionDateStruct": {
            "date": "2010-09",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Ulcerative Colitis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 195,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03220841",
          "briefTitle": "Stricture Definition and Treatment (STRIDENT) Drug Therapy Study"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-10-09",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-09",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Crohn Disease", "Inflammatory Bowel Diseases", "Stricture; Bowel"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 78,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01860846",
          "briefTitle": "Anti-Tumor Necrosis Factor (TNF) Treatments, Work Productivity and Quality of Life in Crohn's Disease"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2013-05"
          },
          "completionDateStruct": {
            "date": "2016-02",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Crohn's Disease"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 106,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06867094",
          "briefTitle": "A Study to Investigate Efficacy and Safety of SAR441566 in Patients With Ulcerative Colitis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-03-28",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2028-05-11",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Colitis Ulcerative"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 204,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04956159",
          "briefTitle": "TMS in Inflammatory Bowel Disease"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-11-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-10-07",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Inflammatory Bowel Diseases", "Maladaptive Behavior Associated With Physical Illness"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 12,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT07196748",
          "briefTitle": "A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-10-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2032-01-13",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Colitis, Ulcerative"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 882,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "12 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05029921",
          "briefTitle": "A Study of Ustekinumab (STELARA) in Chinese Participants With Moderately to Severely Active Crohn's Disease"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-12-10",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-05-18",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Crohn Disease"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 182,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03398148",
          "briefTitle": "A Multicenter, Randomized, Double-Blind, Placebo Controlled Induction Study to Evaluate the Efficacy and Safety of Risankizumab in Participants With Moderately to Severely Active Ulcerative Colitis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-03-07",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-05-11",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Ulcerative Colitis (UC)"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 1558,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "16 Years",
          "maximumAge": "80 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT07065175",
          "briefTitle": "KANGFUPEN Liquid Dressing for Chronic Radiation-Induced Rectal Injury"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-08",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2029-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Chronic Radiation-induced Proctitis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 65,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "80 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03110198",
          "briefTitle": "Mesalazine With Hydrocortisone Sodium Succinate Enema for 4-Week Treatment in Patients With Ulcerative Colitis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-05",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2018-03",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Ulcerative Colitis, Unspecified"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 528,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "70 Years"
        }
      }
    ]
  }
}
